Biểu đồ giá cổ phiếu SNGX
SNGX Dự đoán giá cổ phiếu
Soligenix Inc
$0.42
-70.25%
$-0.99
Khi đóng cửa: Apr 28, 16:00:00 GMT-4
$0.4
-2.75%
$-0.01
Phiên trước giờ: Apr 29, 06:56:38 GMT-4
Quay lại
Soligenix Inc (SNGX) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$1.41
Giá mở cửa
$0.6106
Phạm vi ngày
$0.3701 - $0.6337
Phạm vi 52 tuần
$0.4093 - $6.23
Khối lượng
14.9M
Khối lượng trung bình
224.2K
Tỷ suất cổ tức
--
EPS (TTM)
-2.76
Vốn hóa thị trường
$4.2M
SNGX là gì?
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. The company is headquartered in Princeton, New Jersey and currently employs 14 full-time employees. The Company’s segments include Specialized Biotherapeutics, and Public Health Solutions. Its Specialized BioTherapeutics business segment is engaged in developing and focused on the commercialization of HyBryte (a proposed name of SGX301), a novel photodynamic therapy (PDT), utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). Its Public Health Solutions segment includes development programs for RiVax, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic-resistant and emerging infectious diseases and its vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax, its vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2).
